Cytena and Molecular Devices expand their partnership to launch the f.sight and c.sight in North America

Cytena is x.sighted to announce the launch of the f.sight and c.sight in North America.

Freiburg, Germany - Molecular Devices, LLC, a leader in protein and cell biology technologies, announced an expansion in its partnership with cytena GmbH to launch the x.sight series in North America. Building on cytena`s success of the single-cell printer system, the new family evolves both the ease of use for image-based isolation and documentation of single cells and adds fluorescent sorting for further enrichment of monoclonal cell lines.


EUR 3 million in series A for the growth and development of Cytena GmbH

  • Two private investors and High-Tech Gründerfonds (HTGF) are convinced of the importance of single-cell isolation for the production of biopharmaceuticals and for genetic analysis in research and diagnostics.
  • EUR 3 million will be invested in the further development of the technology, the expansion of the sales organization and in opening up further applications for Cytena's single-cell printers.